• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BIOSENSE WEBSTER INC UNK_NAVISTAR THERMOCOOL

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BIOSENSE WEBSTER INC UNK_NAVISTAR THERMOCOOL Back to Search Results
Catalog Number UNK_NAVISTAR THERMOCOOL
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problems Air Embolism (1697); No Code Available (3191)
Event Date 01/01/2019
Event Type  Injury  
Manufacturer Narrative
(b)(4).Since the product was not returned for analysis, no product failure analysis can be conducted and no determination of possible contributing factors could be made.Device history record (dhr) review cannot be conducted because no lot number was provided by the customer.Information regarding patient weight, height, medical history, race, and ethnicity was not reported.Cerenovus manufacturer's report numbers: 2029046-2020-00087 and 2029046-2020-00089 are related to the same incident.
 
Event Description
This complaint is from a literature source.As reported in the literature publication entitled, ¿impact of preprocedural serum eicosapentaenoic acid to arachidonic acid ratio on post-ablation recurrence of atrial fibrillation¿ (pmid: 31735788).1 patient with atrial fibrillation who underwent first-time radiofrequency catheter ablation which was performed using an open-irrigated ablation catheter navistar thermocool experienced right coronary air embolization that required intervention with aspiration system.192 patients were enrolled.Patients were divided into two groups using the median serum epa/aa ratio.Patient characteristics, electrophysiological findings, and the incidence of af recurrence post ca were compared between the low and high groups.The principle strategy was extensive encircling pulmonary vein isolation (pvi) which was performed using an open-irrigated ablation catheter (navistar thermocool, biosense-webster, (b)(4), usa).We used the double-lasso technique under the guidance of a 3d mapping system (carto xp or carto3) bwi devices were used in this study.No devices specific information (including catalog and lot number) were provided in the article.Concomitant devices were: carto3 or carto xp mapping system.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
UNK_NAVISTAR THERMOCOOL
Type of Device
UNK_NAVISTAR THERMOCOOL
Manufacturer (Section D)
BIOSENSE WEBSTER INC
33 technology drive
irvine CA 92618
Manufacturer (Section G)
BIOSENSE WEBSTER INC (JUAREZ)
circuito interior norte
1820parque industrial salvacar
juarez 32599
MX   32599
Manufacturer Contact
gabriel alfageme
31 technology drive
irvine, CA 92618
949789-868
MDR Report Key9587296
MDR Text Key189499804
Report Number2029046-2020-00088
Device Sequence Number1
Product Code LPB
Combination Product (y/n)N
PMA/PMN Number
UNK
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type foreign,literature
Reporter Occupation Physician
Type of Report Initial
Report Date 12/23/2019
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received01/14/2020
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Catalogue NumberUNK_NAVISTAR THERMOCOOL
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Date Manufacturer Received12/23/2019
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Unknown
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
Patient Age60 YR
-
-